UBS Group
HSCSW icon

UBS Group’s HeartSciences Inc Warrant HSCSW Stock Holding History

UBS Group’s Portfolio HSCSW Stock Details HSCSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54 Hold
1,086
– – ﹤0.01% 10182
2026
Q1 		$71 Buy
1,086
+586
+117% +$55 ﹤0.01% 10164
2025
Q4 		$23 Hold
500
– – ﹤0.01% 10346
2025
Q3 		$70 Buy
+500
New +$54 ﹤0.01% 9978
2025
Q1 		– Sell
-1,500
Closed -$45 – 10442
2024
Q4 		$45 Buy
+1,500
New +$56 ﹤0.01% 9717
2024
Q3 		– Sell
-3,439
Closed -$117 – 9733
2024
Q2 		$117 Buy
+3,439
New +$130 ﹤0.01% 9140
2023
Q4 		– Sell
-1,411
Closed -$63 – 9556
2023
Q3 		$63 Buy
1,411
+1,321
+1,468% +$145 ﹤0.01% 8973
2023
Q2 		$14 Sell
90
-2,503
-97% -$448 ﹤0.01% 8715
2023
Q1 		$568 Buy
2,593
+2,292
+761% +$550 ﹤0.01% 8971
2022
Q4 		$87 Buy
+301
New +$100 ﹤0.01% 10418
2022
Q3 		– Sell
-1
Closed – – 10587
2022
Q2 		$0 Buy
+1
New – ﹤0.01% 10579

Other funds holding HSCSW

CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group's HSCSW Position: Q2 2026 in Review

UBS Group held its HeartSciences Inc Warrant (HSCSW) position steady in Q2 2026 at 1,086 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #10182.

UBS Group first reported a position in HSCSW in Q2 2022 and has held it in 11 quarters since. The position peaked at $568 in Q1 2023. 3 funds tracked by Wall St. Rank hold HSCSW as of Q2 2026.

  • UBS Group held 1,086 shares of HeartSciences Inc Warrant worth $54 as of Q2 2026.
  • UBS Group left its HeartSciences Inc Warrant share count unchanged in Q2 2026.
  • HeartSciences Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10182 holding.
  • UBS Group first reported a position in HeartSciences Inc Warrant in Q2 2022 and has held it in 11 quarters since.
  • UBS Group's HeartSciences Inc Warrant position peaked at $568 in Q1 2023.
  • 3 funds tracked by Wall St. Rank held HeartSciences Inc Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.